Classic Yin and Yang Tonic Formula for Osteopenia (CYYTO)

Randomized Controlled Trial of Classic Yin and Yang Tonic Formula in Osteopenia

The purpose of this study is to evaluate the efficacy and safety of the classic yin and yang tonic formula for osteopenia and to research the mechanism of efficacy.

Study Overview

Status

Unknown

Conditions

Detailed Description

Osteoporosis is a growing problem worldwide, with the greatest burden resulting from fractures. Nevertheless, the majority of fractures in adults occur in those with "osteopenia" (bone mineral density (BMD) only moderately lower than young normal individuals) Since life long drug therapy is an expensive option with uncertain consequences and side effect, natural herbal therapy offers an attractive alternative. The classic Yin and Yang Tonic Formula (eg.Zuogui Pill, Yougui Pill) have been used for osteoporosis or osteopenia in traditional Chinese medicine(TCM) for a long time. For this reason, Chinese guidelines for the treatment of osteopenia include natural herbal therapy, however, there is currently no randomize placebo controlled trial to verify the efficacy for treating low BMD. This trial is randomized, double blind, placebo controlled design. Results of this study will provide evidence regarding the value of the classic Yin and Yang tonic formula as an intervention for increase BMD and decreasing fracture risk in osteopenia. Furthermore, the mechanisms of action can be identified by this study.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200032
        • Recruiting
        • Longhua Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMD T-scores of the hip (femoral neck or trochanter)and/or spine between -1.0 and -2.5;
  • pattern differentiation is kidney deficiency in TCM.
  • informed consent.

Exclusion Criteria:

  • Osteoporotic (T-score< -2.5) at any site or a fracture in the past 2 years not caused by motor vehicle accident;
  • prior or current use of medication that increase risks of fracture (e.g. steroids, anti-convulsants, anticoagulants,lithium);
  • prior or current use of medications that modify bone metabolism (e.g. bisphosphonates, selective estrogen receptor modulators such as Raloxifene);
  • use of calcium supplements above levels suggested within the recommendations of standard care (i.e., above 1200-1500 mg);
  • current or prior year use of estrogen or calcitonin;
  • Malignancies other than skin cancer;
  • conditions that cause secondary osteoporosis (e.g. Cushing's syndrome, Marfan's syndrome);
  • lactation and gestational period;
  • physical or mental disabilities that will preclude informed consent or active study participation;
  • supersensitivity body constitution.
  • osteoporotic fracture of having operating indication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: placebo
granules,18g per time,two times per day,six months
Other Names:
  • Zuo and You gui Granules
Experimental: chinese herb
Yin and Yang tonic granules,18g per time,two times per day,six months
Other Names:
  • Zuo and You gui Granules

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
bone mineral density
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain visual analogue scales,ECOS-16 questionnaire,bone metabolism,NEI.
Time Frame: 6 months
pain visual analogue scales:6month ECOS-16 questionnaire:6month bone metabolism,NEI:6month
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: feng yang, doctor, Shanghai UTCM

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Anticipated)

January 1, 2012

Study Completion (Anticipated)

July 1, 2012

Study Registration Dates

First Submitted

January 3, 2011

First Submitted That Met QC Criteria

January 6, 2011

First Posted (Estimate)

January 7, 2011

Study Record Updates

Last Update Posted (Estimate)

July 28, 2011

Last Update Submitted That Met QC Criteria

July 26, 2011

Last Verified

January 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • LHCTOP2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteopenia

Clinical Trials on Yin and Yang tonic granules

3
Subscribe